Clinical trials: Lumbosacral Radiculopathy
Radiculopathy Lumbar, Degenerative Lumbar Disc Disease
Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes
The goal of this clinical trial is to assess the safety and effectiveness of the study device, CORUS-LX, as an adjunct to lumbar interbody fusion, when used in combination with pedicle screw and rod constructs for the treatment…
- Trial name
- ILIF (NCT07222787)
- Testing
- Supplemental Posterior Fusion with Study Device, Supplemental Posterior Fusion with Standard Technique
- Where
- 12 sites in United States
- Volunteers
- 250 people
- Sponsor
- Providence Medical Technology, Inc.
Lumbosacral Radicular Pain, Sciatic Radiculopathy
Study to Evaluate Safety of C-1101 Versus Sterile Saline in Adults With Chronic Painful Lumbosacral Radiculopathy
The purpose of this study is to evaluate the safety and tolerability of C-1101 administered as a single dose, transforaminal epidural injection compared to sterile saline
- Conditions
- Lumbosacral Radicular Pain, Sciatic Radiculopathy, Sciatic Leg Pain, Sciatica
- Trial name
- NCT07264270
- Testing
- C-1101
- Where
- 6 sites in United States, Australia
- Volunteers
- 24 people
- Sponsor
- Consano Bio
Lumbosacral Radiculopathy
A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Study
This is a long-term, 3-year, follow-up study for patients completing the KS-GIG-001-01 Study
- Trial name
- NCT05613569
- Testing
- KLS-2031
- Where
- United States
- Volunteers
- 5 people
- Sponsor
- Kolon Life Science
Lumbosacral Radiculopathy
Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults
This study will evaluate the safety and effectiveness of a new pain medication in development, clonidine micropellet. Participants will receive a single injection of either clonidine micropellet or sham injection for the…
- Trial name
- RePRIEVE-CM (NCT03727100)
- Testing
- Clonidine Micropellets
- Where
- 33 sites in United States
- Volunteers
- 207 people
- Sponsor
- Sollis Therapeutics, Inc.